Year 2016 / Volume 108 / Number 7
Original
Meta-analysis of the association between appendiceal orifice inflammation and appendectomy and ulcerative colitis

401-410

DOI: 10.17235/reed.2016.4176/2015

Peng Deng, Junchao Wu,

Abstract
Objective: This study aimed to investigate the relationship between appendiceal orifice inflammation (AOI) and appendectomy and ulcerative colitis (UC) by a meta-analysis. Methods: Databases were thoroughly searched for studies on AOI and UC up to January 2016. Three comparisons were performed: a) whether the previous appendectomy was a risk factor of UC; b) influence of appendectomy on UC courses; c) influence of AOI on UC severity. Odds ratios (ORs) and 95% confidence intervals (CIs) were the effects sizes. The merging of results and publication bias assessment were performed by using RevMan 5.3. Sensitivity analysis was conducted using Stata 12.0. Results: Nineteen studies were selected in the present study. Results of comparison I showed that appendectomy was a protective factor of UC (OR = 0.44; 95% CI [0.30, 0.64]). Comparison II indicated appendectomy had no significant influence in the courses of UC (proctitis: OR = 1.03, 95% CI [0.74, 1.42]; left-sided colitis: OR = 1.01, 95% CI [0.73, 1.39]; pancolitis: OR = 0.92, 95% CI [0.59, 1.43]; colectomy: OR = 1.38, 95% CI [0.62, 3.04]). Comparison III indicated UC combined with AOI did not affect the courses of UC (proctitis: OR = 1.15, 95% CI [0.67, 1.98]; left-sided colitis: OR = 1.14, 95% CI [0.24, 5.42]; colectomy: OR = 0.36, 95% CI [0.10, 1.23]). Sensitivity analysis confirmed the robust of the results in the present study. Conclusion: In conclusion, this meta-analysis indicated appendectomy can reduce the risk of UC. But appendectomy or AOI had no influence on the severity of the disease and the effect of surgical treatment.
Share Button
New comment
Comments
No comments for this article
References
1. Klement G, Huang P, Mayer B, et al. Differences in therapeutic indexes of combination metronomic chemotherapy and an anti-VEGFR-2 antibody in multidrug-resistant human breast cancer xenografts. Clin Cancer Res 2002; 8: 221-32.
2. Sugiyama Y, Saji S, Miya K, et al. [Therapeutic effect of multimodal therapy, such as cryosurgery, locoregional immunotherapy and systemic chemotherapy against far advanced breast cancer]. Gan To Kagaku Ryoho 2001; 28: 1616-9.
3. Seroussi B, Bouaud J , Antoine E C. Users' evaluation of OncoDoc, a breast cancer therapeutic guideline delivered at the point of care. Proc AMIA Symp 1999: 384-9.
4. Goldstone R, Itzkowitz S, Harpaz N, et al. Dysplasia is more common in the distal than proximal colon in ulcerative colitis surveillance. Inflamm Bowel Dis 2012; 18: 832-7.
5. Castiglione F, Diaferia M, Morace F, et al. Risk factors for inflammatory bowel diseases according to the "hygiene hypothesis": a case-control, multi-centre, prospective study in Southern Italy. J Crohns Colitis 2012; 6: 324-9.
6. Florin TH, Pandeya N, Radford-Smith G L. Epidemiology of appendicectomy in primary sclerosing cholangitis and ulcerative colitis: its influence on the clinical behaviour of these diseases. Gut 2004; 53: 973-9.
7. Gearry RB, Richardson AK, Frampton CM, et al. Population-based cases control study of inflammatory bowel disease risk factors. J Gastroenterol Hepatol 2010; 25: 325-33.
8. Inoue K, Tabei T, Suemasu K, et al. [Therapeutic efficacy of pirarubicin cyclophosphamide and doxifluridine in advanced and metastatic breast cancer]. Gan To Kagaku Ryoho 1999; 26: 637-42.
9. Alexandre J, Faivre S, Sutherland W, et al. Effects of adjuvant chemotherapy on the natural history and likelihood of therapeutic efficacy in advanced breast cancer patients: a critical literature review. Cancer Treat Rev 1998; 24: 393-406.
10. Valero V, Hortobagyi GN. Primary chemotherapy: a better overall therapeutic option for patients with breast cancer. Ann Oncol 1998; 9: 1151-4.
11. Namer M, Ramaioli A, Hery M, et al. [Prognostic factors and therapeutic strategy of breast cancer]. Rev Prat 1998; 48: 45-51.
12. Samarel N, Fawcett J, Davis MM, et al. Effects of dialogue and therapeutic touch on preoperative and postoperative experiences of breast cancer surgery: an exploratory study. Oncol Nurs Forum 1998; 25: 1369-76.
13. Elstner E, Williamson E A, Zang C, et al. Novel therapeutic approach: ligands for PPARgamma and retinoid receptors induce apoptosis in bcl-2-positive human breast cancer cells. Breast Cancer Res Treat 2002; 74: 155-65.
14. Huber S, Ulsperger E, Gomar C, et al. Osseous metastases in breast cancer: radiographic monitoring of therapeutic response. Anticancer Res 2002; 22: 1279-88.
15. Byeon JS, Yang SK, Myung SJ, et al. Clinical course of distal ulcerative colitis in relation to appendiceal orifice inflammation status. Inflamm Bowel Dis 2005; 11: 366-71.
16. Perry W B, Opelka F G, Smith D, et al. Discontinuous appendiceal involvement in ulcerative colitis: pathology and clinical correlation. J Gastrointest Surg 1999; 3: 141-4.
17. Yamagishi N, Iizuka B, Nakamura T, et al. Clinical and colonoscopic investigation of skipped periappendiceal lesions in ulcerative colitis. Scand J Gastroenterol 2002; 37: 177-82.
18. Park SH, Loftus EV Jr, Yang SK. Appendiceal Skip Inflammation and Ulcerative Colitis. Dig Dis Sci. 2014 ;59:2050-7.
19. Ko Y, Kariyawasam V, Karnib M, et al. Inflammatory Bowel Disease Environmental Risk Factors: A Population-Based Case-Control Study of Middle Eastern Migration to Australia. Clin Gastroenterol Hepatol 2015; 13: 1453-63 e1.
20. Selby W S, Griffin S, Abraham N, et al. Appendectomy protects against the development of ulcerative colitis but does not affect its course. Am J Gastroenterol 2002; 97: 2834-8.
21. Wells G, Shea B, O’connell D, et al., The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000.
22. Higgins J, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60.
23. Cosnes J, Carbonnel F, Beaugerie L, et al. Effects of appendicectomy on the course of ulcerative colitis. Gut 2002; 51: 803-7.
24. Hallas J, Gaist D, Vach W, et al. Appendicectomy has no beneficial effect on admission rates in patients with ulcerative colitis. Gut 2004; 53: 351-4.
25. Hlavaty T, Toth J, Koller T, et al. Smoking, breastfeeding, physical inactivity, contact with animals, and size of the family influence the risk of inflammatory bowel disease: A Slovak case-control study. United European Gastroenterol J 2013; 1: 109-19.
26. Lee HS, Park SH, Yang SK, et al. Appendectomy and the clinical course of ulcerative colitis: a retrospective cohort study and a nested case-control study from Korea. J Gastroenterol Hepatol 2015; 30: 470-7.
27. Lopez-Serrano P, Perez-Calle JL, Perez-Fernandez MT, et al. Environmental risk factors in inflammatory bowel diseases. Investigating the hygiene hypothesis: a Spanish case-control study. Scand J Gastroenterol 2010; 45: 1464-71.
28. Naganuma M, Iizuka B, Torii A, et al. Appendectomy protects against the development of ulcerative colitis and reduces its recurrence: results of a multicenter case-controlled study in Japan. Am J Gastroenterol 2001; 96: 1123-6.
29. Naves J E, Lorenzo-Zuniga V, Marin L, et al. Long-term outcome of patients with distal ulcerative colitis and inflammation of the appendiceal orifice. J Gastrointestin Liver Dis 2011; 20: 355-8.
30. Radford-Smith GL, Edwards JE, Purdie DM, et al. Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn's disease. Gut 2002; 51: 808-13.
31. Selby WS, Griffin S, Abraham N, et al. Appendectomy protects against the development of ulcerative colitis but does not affect its course. Am J Gastroenterol 2002; 97: 2834-8.
32. Wang YF, Ou-Yang Q, Xia B, et al. Multicenter case-control study of the risk factors for ulcerative colitis in China. World J Gastroenterol 2013; 19: 1827-33.
33. Picazo-Ferrera K, Bustamante-Quan Y, Santiago-Hernandez J, et al. [The role of appendectomy in the ulcerative colitis in Mexico]. Rev Gastroenterol Mex 2011; 76: 316-21.
34. Uzan A, Jolly D, Berger E, et al. [Protective effect of appendectomy on the development of ulcerative colitis. A case-control study]. Gastroenterol Clin Biol 2001; 25: 239-42.
35. Kaplan G G, Jackson T, Sands B E, et al. The Risk of Developing Crohn's Disease After an Appendectomy: A Meta-Analysis. Am J Gastroenterol 2008; 103: 2925-31.
36. Selby W S, Griffin S, Abraham N, et al. Appendectomy protects against the development of ulcerative colitis but does not affect its course. Am J Gastroenterol 2002; 97: 2834-8.
Related articles

Letter

Tofacitinib-induced eosinophilia

DOI: 10.17235/reed.2023.9831/2023

Letter

Perianal Paget’s disease

DOI: 10.17235/reed.2022.9304/2022

Letter

Chinese dragon sign of ulcerative colitis

DOI: 10.17235/reed.2022.9154/2022

Letter

Ulcerative colitis exacerbated by strongyloidiasis

DOI: 10.17235/reed.2022.9044/2022

Letter

Mesalazine induced interstitial pneumonitis in the COVID era

DOI: 10.17235/reed.2022.8635/2021

Letter

The effect of Adacolumn® on ulcerative colitis with COVID-19

DOI: 10.17235/reed.2020.7156/2020

Letter

Sweet syndrome in severe ulcerative flare

DOI: 10.17235/reed.2020.6995/2020

Letter to the Editor

Ulcerative colitis with gastric and duodenal involvement

DOI: 10.17235/reed.2017.4685/2016

Editorial

Specialist care in the management of inflammatory bowel disease

DOI: 10.17235/reed.2016.4628/2016

Original

Mercaptopurine and inflammatory bowel disease: the other thiopurine

DOI: 10.17235/reed.2016.4546/2016

Case Report

Mesalamine-induced myopericarditis - A case report

DOI: 10.17235/reed.2016.4016/2015

Citation tools
Deng P, Wu J. Meta-analysis of the association between appendiceal orifice inflammation and appendectomy and ulcerative colitis. 4176/2015


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 583 visits.
This article has been downloaded 92 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 26/12/2015

Accepted: 04/02/2016

Online First: 24/06/2016

Published: 11/07/2016

Article revision time: 36 days

Article Online First time: 181 days

Article editing time: 198 days


Share
This article hasn't been rated yet.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology